Contec Medical Systems Co.,Ltd (SHE:300869)
China · Delayed Price · Currency is CNY 10.68
-0.16 (-1.48%)
Jun 11, 2026, 2:55 PM CST
SHE:300869 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Net Income | -49.1 | -24.42 | -77.9 | 165.77 | 196.2 | 352.35 |
Depreciation & Amortization | 27.38 | 27.38 | 27.95 | 27.52 | 20.59 | 17.86 |
Other Amortization | 0.17 | 0.17 | 0.02 | - | - | - |
Loss (Gain) From Sale of Assets | 0.17 | 0.17 | 0.09 | 0.07 | 0.26 | 0.04 |
Asset Writedown & Restructuring Costs | - | - | - | - | 0.01 | 10.72 |
Loss (Gain) From Sale of Investments | -18.5 | -18.5 | -24.11 | -13.49 | -54.6 | -1.58 |
Provision & Write-off of Bad Debts | -1.35 | -1.35 | 1.44 | -1.03 | 2.02 | 0.38 |
Other Operating Activities | 70.23 | 48.88 | 109.1 | 32.7 | -40.98 | -115.35 |
Change in Accounts Receivable | -10.46 | -10.46 | -13.88 | 148.68 | -64.49 | -23.01 |
Change in Inventory | 14.59 | 14.59 | 74.03 | -85.05 | -17.39 | -144.98 |
Change in Accounts Payable | -10.72 | -10.72 | -36.56 | -78.3 | 59.34 | -93.11 |
Operating Cash Flow | 18.97 | 22.29 | 62.34 | 181.01 | 103.66 | 4.65 |
Operating Cash Flow Growth | -79.57% | -64.25% | -65.56% | 74.63% | 2130.42% | -99.22% |
Capital Expenditures | -48.36 | -49.48 | -54.46 | -30.74 | -81.45 | -106.31 |
Sale of Property, Plant & Equipment | 0.14 | 0.14 | 0.95 | 0.11 | 0.25 | 0.12 |
Investment in Securities | 144.68 | 224.85 | -170.24 | -750 | -50 | 50 |
Other Investing Activities | 188.03 | 52.27 | 118.08 | 57.67 | 17.37 | 5.09 |
Investing Cash Flow | 284.49 | 227.79 | -105.68 | -722.96 | -113.82 | -51.09 |
Short-Term Debt Issued | - | 275 | 90 | 632.88 | 874.88 | 915.2 |
Long-Term Debt Issued | - | - | - | - | 690.1 | - |
Total Debt Issued | 268.56 | 275 | 90 | 632.88 | 1,565 | 915.2 |
Short-Term Debt Repaid | - | -120 | -377 | -1.06 | -787.05 | -312.1 |
Long-Term Debt Repaid | - | -1.43 | -2.21 | -1,191 | -1.87 | -0.35 |
Total Debt Repaid | -136.85 | -121.43 | -379.21 | -1,192 | -788.92 | -312.45 |
Net Debt Issued (Repaid) | 131.71 | 153.57 | -289.21 | -559.54 | 776.06 | 602.75 |
Common Dividends Paid | -112.9 | -112.11 | -127.72 | -68.7 | -123.92 | -102.31 |
Other Financing Activities | -0.18 | 22.06 | 673.18 | 244.79 | 129.2 | -666.06 |
Financing Cash Flow | 18.63 | 63.52 | 256.26 | -383.44 | 781.34 | -165.62 |
Foreign Exchange Rate Adjustments | -28.19 | -15.18 | 4.16 | 5.28 | 17.58 | -2.5 |
Net Cash Flow | 293.9 | 298.42 | 217.08 | -920.1 | 788.75 | -214.56 |
Free Cash Flow | -29.4 | -27.19 | 7.88 | 150.28 | 22.21 | -101.66 |
Free Cash Flow Growth | - | - | -94.75% | 576.62% | - | - |
Free Cash Flow Margin | -6.44% | -5.81% | 1.64% | 20.12% | 3.12% | -11.19% |
Free Cash Flow Per Share | -0.07 | -0.07 | 0.02 | 0.36 | 0.05 | -0.25 |
Cash Income Tax Paid | 12.67 | 7.74 | 40.69 | 34.94 | 9.9 | 60.8 |
Levered Free Cash Flow | -44.04 | 411.69 | -449.48 | 70.11 | -46.16 | -97.74 |
Unlevered Free Cash Flow | -13.42 | 435.09 | -427.42 | 98.3 | -34.24 | -95.95 |
Change in Working Capital | -10.03 | -10.03 | 25.77 | -30.52 | -19.85 | -259.78 |